Dr. Elvira Parravicini was born and raised in Milan, Italy. She graduated at the University of Milan, Italy in 1981. She completed her Pediatric residency in 1985 and Neonatal fellowship in 1986 at the same University of Milan. Dr. Parravicini worked for 6 years as attending neonatologist at the Hospital of Monza, associated with the University of Milan.
In 1993 she was appointed Medical Director of a project of AVSI (an Italian NGO) supported by the Italian Ministry of Foreign Affairs at the St. Kizito Clinic in Lagos, Nigeria.
In 1994 she moved to the United States, where she completed her Pediatric residency at New York University in 1997 and her Neonatal fellowship at Columbia University in 2001.
Starting in 2001 she has been working as attending neonatologist at New York Presbyterian Morgan Stanley Children’s Hospital and Assistant Professor of Pediatrics at Columbia University.
Dr. Parravicini has been working on kidney development. Currently her major focus is the study of urine NGAL (Neutrophil Gelatinase Associated Lipocalin) as an early biomarker of acute renal failure and sepsis in very low birth weight infants.
However her primary interest is prenatal diagnosis and post-natal treatment of infants affected by life-limiting conditions. She was the founder and is currently the medical director of the Neonatal Comfort Care program at Columbia University Medical Center. This is a multidisciplinary team, supporting infants with life-limiting or terminal conditions and their families.